Shopping Cart 0
Cart Subtotal
USD 0

Cellect Biotechnology Ltd (APOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company's technology platform is developing ApoGraft solutions which provides functional selection of stem and progenitor cells through an apoptotic process with focus on hematopoietic cells field. It is developing ApoTainer selection kit, a off-the-shelf medical device product for use in bone marrow transplantation, immune disorders and organ transplantations. The company offers licensing opportunities to pharmaceutical companies, medical research centers, academies and hospitals with the tools to rapidly isolate stem cells and allow stem cell related treatments and procedures. Cellect Biotechnology is headquartered in Kfar Saba, Israel.

Cellect Biotechnology Ltd (APOP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 12

Accellta Enters into Agreement with Cellect Biomed 13

Equity Offering 14

Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 14

Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 15

Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 17

Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 19

Cellect Biotech Raises Funds through Private Placement of Shares 20

Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 21

Cellect Biotech to Raise USD1 Million in Private Placement of Shares 22

Cellect Biotechnology Ltd-Key Competitors 23

Cellect Biotechnology Ltd-Key Employees 24

Cellect Biotechnology Ltd-Locations And Subsidiaries 25

Head Office 25

Recent Developments 26

Financial Announcements 26

May 17, 2018: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2018 Financial Results 26

Mar 19, 2018: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results 27

Nov 22, 2017: Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2017 Financial Results 29

Aug 21, 2017: Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2017 Financial Results 30

May 29, 2017: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2017 Financial Results 31

Mar 23, 2017: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results 32

Corporate Communications 34

May 10, 2018: Former GE Healthcare Executive to Join Cellect as Chief Business Officer 34

Oct 19, 2017: Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer 35

Jun 09, 2017: Cellect is Moving to Trade Exclusively on the NASDAQ 36

May 23, 2017: David Braun, Head of Merck Device Business, Joins Cellect's Advisory Board 37

Mar 02, 2017: Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect's Board of Directors 38

Feb 23, 2017: World-Renowned Stem Cell Transplantation Expert joins Cellect's Advisory Board 39

Feb 14, 2017: Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange 40

Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer 41

Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer 42

Product News 43

03/27/2017: Cellect Announces Successful First Cancer Patient Stem Cell Transplant 43

02/21/2017: Cellect Announces Positive Clinical Trial Results 44

02/08/2017: First Cancer Patient Treated In Phase I/II Trial of ApoGraft 45

Product Approvals 46

Sep 05, 2017: FDA Grants Orphan Drug Status to Cellect's ApoGraft for Acute GvHD and Chronic GvHD 46

May 03, 2017: Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S. 47

Other Significant Developments 48

Apr 09, 2018: Cellect Announces a Major Milestone for Enabling Stem Cells Production 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Cellect Biotechnology Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 12

Accellta Enters into Agreement with Cellect Biomed 13

Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 14

Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 15

Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 17

Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 19

Cellect Biotech Raises Funds through Private Placement of Shares 20

Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 21

Cellect Biotech to Raise USD1 Million in Private Placement of Shares 22

Cellect Biotechnology Ltd, Key Competitors 23

Cellect Biotechnology Ltd, Key Employees 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Cellect Biotechnology Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.